Jackson Square Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Jackson Square Capital, LLC

  • $387 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Mar 05, 2021
SELL
$478.3 - $607.98 $11,000 - $13,983
-23 Closed
0 $0
Q2 2020

Aug 18, 2020
SELL
$493.32 - $643.92 $986 - $1,287
-2 Reduced 8.0%
23 $14,000
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $672 - $988
2 Added 8.7%
25 $12,000
Q4 2019

May 15, 2020
BUY
$274.13 - $376.51 $6,304 - $8,659
23 New
23 $9,000

Others Institutions Holding REGN

# of Institutions
1,464
Shares Held
84.4M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $109B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Jackson Square Capital, LLC Portfolio

Follow Jackson Square Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email